España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Relay Therapeutics
RLAY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.62
-0.05
-0.98%
Pre-Market: 4:57 PM EDT
Get Report
Comment
Relay Therapeutics (RLAY) Forecast
News
Earnings
Relay Therapeutics (RLAY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Relay Therapeutics (NASDAQ:RLAY) Stock
Relay Therapeutics Stock (NASDAQ: RLAY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk
Wednesday, November 06, 2024
Relay Therapeutics Q3 2024 GAAP EPS $(0.63) B...
Benzinga Newsdesk
Monday, October 14, 2024
HC Wainwright & Co. Reiterates Buy on Relay T...
Benzinga Newsdesk
Tuesday, September 17, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, September 16, 2024
Stifel Reiterates Buy on Relay Therapeutics, ...
Benzinga Newsdesk
Relay Therapeutics shares are trading are tra...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk
Wednesday, September 11, 2024
Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
Henry Khederian
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
Avi Kapoor
GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Relay Therapeutics shares are trading lower a...
Benzinga Newsdesk
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, Relay Therapeutics Prices $...
Benzinga Newsdesk
Tuesday, September 10, 2024
Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
Vandana Singh
B of A Securities Maintains Buy on Relay Ther...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Relay Thera...
Benzinga Newsdesk
Barclays Maintains Overweight on Relay Therap...
Benzinga Newsdesk
Relay Therapeutics shares are trading lower a...
Benzinga Newsdesk
This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Avi Kapoor
Goldman Sachs Reinstates Buy on Relay Therape...
Benzinga Newsdesk
Jefferies Upgrades Relay Therapeutics to Buy,...
Benzinga Newsdesk
Oppenheimer Downgrades Relay Therapeutics to ...
Benzinga Newsdesk
Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
Avi Kapoor
Monday, September 09, 2024
Relay Therapeutics Commences Public Offering ...
Benzinga Newsdesk
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
Avi Kapoor
Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
Avi Kapoor
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
Vandana Singh
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
Avi Kapoor
US Stocks Higher; Dow Surges Over 200 Points
Avi Kapoor
Relay Therapeutics shares are trading higher ...
Benzinga Newsdesk
Relay Therapeutics Reports Interim Data for B...
Benzinga Newsdesk
Wednesday, August 07, 2024
JP Morgan Maintains Overweight on Relay Thera...
Benzinga Newsdesk
Expert Ratings For Relay Therapeutics
Benzinga Insights
Oppenheimer Maintains Outperform on Relay The...
Benzinga Newsdesk
Tuesday, August 06, 2024
Relay Therapeutics Q2 2024 GAAP EPS $(0.69) B...
Benzinga Newsdesk
Friday, July 26, 2024
Barclays Maintains Overweight on Relay Therap...
Benzinga Newsdesk
Thursday, July 18, 2024
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Wednesday, July 17, 2024
Expert Ratings For Relay Therapeutics
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Relay Th...
Benzinga Newsdesk
Tuesday, July 16, 2024
Relay Therapeutics Receives Notice Of Termina...
Benzinga Newsdesk
Friday, June 07, 2024
Expert Ratings For Relay Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Relay T...
Benzinga Newsdesk
Thursday, June 06, 2024
Relay Therapeutics Cash Guidance Remains Unch...
Benzinga Newsdesk
Relay Therapeutics Discloses Three New Progra...
Benzinga Newsdesk
Wednesday, June 05, 2024
Relay Therapeutics And Pfizer Collaborate On ...
Benzinga Newsdesk
Friday, May 10, 2024
Key Takeaways From Relay Therapeutics Analyst Ratings
Benzinga Insights
Barclays Upgrades Relay Therapeutics to Overw...
Benzinga Newsdesk
Monday, May 06, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Relay Th...
Benzinga Newsdesk
Thursday, May 02, 2024
Relay Therapeutics Q1 2024 GAAP EPS $(0.62) B...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch